Recognition and management of pulmonary hypertension.
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 56 (6) , 989-1007
- https://doi.org/10.2165/00003495-199856060-00004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolismIntensive Care Medicine, 1996
- Aerosolized Prostacyclin Versus Inhaled Nitric Oxide in Children with Severe Acute Respiratory Distress SyndromeAnesthesiology, 1995
- Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose responseThe Journal of Pediatrics, 1994
- Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue diseaseThe American Journal of Cardiology, 1991
- Prostacyclin for the Treatment of Pulmonary Hypertension in the Adult Respiratory Distress SyndromeAnesthesiology, 1990
- The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.Circulation, 1985
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation, 1984
- Sustained beneficial effect of nifedipine in primary pulmonary hypertensionAmerican Heart Journal, 1983
- Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation, 1982
- Heart-Lung TransplantationNew England Journal of Medicine, 1982